Original language | English |
---|---|
Journal | Nature Reviews Gastroenterology & Hepatology |
Early online date | 31 May 2023 |
DOIs | |
Publication status | E-pub ahead of print - 31 May 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Nature Reviews Gastroenterology & Hepatology, 31.05.2023.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - A roadmap for the human gut cell atlas
AU - Zilbauer, Matthias
AU - James, Kylie
AU - Kaur, Mandeep
AU - Pott, Sebastian
AU - Li, Zhixing
AU - Burger, Albert
AU - Thiagarajah, Jay
AU - Burclaff, Joseph
AU - Jahnsen, Frode L
AU - Perrone, Francesca
AU - Ross, Alexander
AU - Matteoli, Gianluca
AU - Stakenborg, Nathalie
AU - Sujino, Tomohisa
AU - Moor, Andreas
AU - Bartolome-Casado, Raquel
AU - Baekkevold, Espen S.
AU - Zhou, Ran
AU - Xie, Bingqing
AU - Lau, Ken
AU - Din, Shahida
AU - Magnes, Scott
AU - Yao, Qiuming
AU - Beyaz, Semir
AU - Arends, Mark J
AU - Denadai-Souza, Alexandre
AU - Coburn, Lori
AU - Gaublomme, Jellert
AU - Baldock, Richard
AU - Papatheodorou, Irene
AU - Ordovas-Montanes, Jose
AU - Boeckxstaens, Guy E
AU - Hupalowska, Anna
AU - Teichmann, Sarah A
AU - Regev, Aviv
AU - Xavier, Ramnik
AU - Simmons, Alison
AU - Snyder, Michael P.
AU - Wilson, Keith
N1 - Funding Information: In the past 3 years, S.A.T. has consulted or been a member of scientific advisory boards at Roche, Genentech, Biogen, GlaxoSmithKline, Qiagen and ForeSite Labs and is an equity holder of Transition Bio. G.M. has received grant funding from Boehringer Ingelheim. A. Regev is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was a SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. Since 1 August 2020, A. Regev has been an employee of Genentech and has equity in Roche. A. Regev is an inventor on patents and patent applications filed at the Broad Institute related to single-cell genomics. The remaining authors declare no competing interests. Funding Information: This publication is part of the Human Cell Atlas (HCA) www.humancellatlas.org/publications . The HCA initiative receives funding from The Wellcome Trust, the UK Research and Innovation Medical Research Council, EU Horizon 2020, INSERM (HuDeCA), and the Knut and Alice Wallenberg and Erling-Persson foundations. We thank the HCA Executive Office for their support. The Gut Cell Atlas is organized by The Leona M. and Harry B. Helmsley Charitable Trust and provides funding for members in the form of project grants. M.Z. was supported by an MRC New Investigator research grant (MR/T001917/1) and a project grant from the Great Ormond Street Hospital Children’s Charity, Sparks (V4519); K.S.L. was supported by NIDDK R01DK103831, and The Helmsley Trust — G-1903-03793. S.T.M. received funding from National Institutes of Health USA R01DK115806 and P30DK034987. T.S. was supported by the Japanese Science and Technology (JST) FOREST and the Japanese Society for the Promotion of Science (JSPS) (21K18272). L.A.C. and K.T.W. were supported by The Helmsley Charitable Trust — G-1903-03793. K.T.W. was also supported by NIDDK R01DK128200. L.A.C. was supported by a Veterans Affairs Merit Award 1I01BX004366. M.K. was supported by the National Research Foundation, South Africa grant no: 129356. Publisher Copyright: © 2023, Springer Nature Limited.
PY - 2023/5/31
Y1 - 2023/5/31
U2 - 10.1038/s41575-023-00784-1
DO - 10.1038/s41575-023-00784-1
M3 - Article
SN - 1759-5045
JO - Nature Reviews Gastroenterology & Hepatology
JF - Nature Reviews Gastroenterology & Hepatology
ER -